117 related articles for article (PubMed ID: 9473020)
1. Predictive factors of occurrence of cytomegalovirus disease and impact on survival in the Aquitaine Cohort in France, 1985 to 1994. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
Saillour F; Bernard N; Dequae-Merchadou L; Marimoutou C; Journot V; Dabis F
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):171-8. PubMed ID: 9473020
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
Binquet C; Saillour F; Bernard N; Rougier MB; Leger F; Bonnal F; Dabis F
Eur J Epidemiol; 2000 May; 16(5):425-32. PubMed ID: 10997829
[TBL] [Abstract][Full Text] [Related]
3. Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
Chêne G; Binquet C; Moreau JF; Neau D; Pellegrin I; Malvy D; Ceccaldi J; Lacoste D; Dabis F
AIDS; 1998 Dec; 12(17):2313-20. PubMed ID: 9863874
[TBL] [Abstract][Full Text] [Related]
4. Incidence of cytomegalovirus disease in the Aquitaine cohort of HIV-infected patients: a retrospective survey, 1987-1993. Groupe d'Epidémilogie Clinique du SIDA en Aquitaine (GECSA).
Saillour F; Bernard N; Ragnaud JM; Morlat P; Blanchard Y; Monlun E; Labouyrie E; Chene G; Dabis F
J Infect; 1997 Sep; 35(2):155-61. PubMed ID: 9354350
[TBL] [Abstract][Full Text] [Related]
5. Progression of human immunodeficiency virus infection in patients with tuberculosis disease. A cohort study in Bordeaux, France, 1988-1994. The Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).
Leroy V; Salmi LR; Dupon M; Sentilhes A; Texier-Maugein J; Dequae L; Dabis F; Salamon R
Am J Epidemiol; 1997 Feb; 145(4):293-300. PubMed ID: 9054232
[TBL] [Abstract][Full Text] [Related]
6. Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. The Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
Morlat P; Parneix P; Douard D; Lacoste D; Dupon M; Chêne G; Pellegrin JL; Ragnaud JM; Dabis F
AIDS; 1992 Oct; 6(10):1187-93. PubMed ID: 1466851
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus: Aquitaine Cohort, France, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
Thiessard F; Morlat P; Marimoutou C; Labouyrie E; Ragnaud JM; Pellegrin JL; Dupon M; Dabis F
Cancer; 2000 Apr; 88(7):1696-702. PubMed ID: 10738229
[TBL] [Abstract][Full Text] [Related]
8. Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).
Thiébaut R; Malvy D; Marimoutou C; Davis F
Eur J Epidemiol; 2000; 16(7):633-9. PubMed ID: 11078120
[TBL] [Abstract][Full Text] [Related]
9. Serum triglycerides, HIV infection, and highly active antiretroviral therapy, Aquitaine Cohort, France, 1996 to 1998. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).
Thiébaut R; Dabis F; Malvy D; Jacqmin-Gadda H; Mercié P; ValentinVD
J Acquir Immune Defic Syndr; 2000 Mar; 23(3):261-5. PubMed ID: 10839662
[TBL] [Abstract][Full Text] [Related]
10. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
Salmon-Céron D; Mazeron MC; Chaput S; Boukli N; Senechal B; Houhou N; Katlama C; Matheron S; Fillet AM; Gozlan J; Leport C; Jeantils V; Freymuth F; Costagliola D
AIDS; 2000 May; 14(8):1041-9. PubMed ID: 10853987
[TBL] [Abstract][Full Text] [Related]
11. Seroepidemiology of cytomegalovirus in patients with advanced HIV disease: influence on disease expression and survival.
Shepp DH; Moses JE; Kaplan MH
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):460-8. PubMed ID: 8605591
[TBL] [Abstract][Full Text] [Related]
12. A cohort study of 89 HIV-1-infected adult patients contaminated by blood products: Bordeaux 1981-1989. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
Msellati P; Dupon M; Morlat P; Lacoste D; Pellegrin JL; Dabis F
AIDS; 1990 Nov; 4(11):1105-9. PubMed ID: 2282183
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus.
Gérard L; Leport C; Flandre P; Houhou N; Salmon-Céron D; Pépin JM; Mandet C; Brun-Vézinet F; Vildé JL
Clin Infect Dis; 1997 May; 24(5):836-40. PubMed ID: 9142778
[TBL] [Abstract][Full Text] [Related]
14. Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts.
Yazdanpanah Y; Chêne G; Losina E; Goldie SJ; Merchadou LD; Alfandari S; Seage GR; Sullivan L; Marimoutou C; Paltiel AD; Salamon R; Mouton Y; Freedberg KA
Int J Epidemiol; 2001 Aug; 30(4):864-71. PubMed ID: 11511618
[TBL] [Abstract][Full Text] [Related]
15. [CD8 hyperlymphocytosis in HIV infection. 63 cases. GECSA (Groupe d'Epidémiologie Clinique du SIDA en Aquitaine)].
Constans J; Ladner J; Dabis F; Brossard G; Commenges D; Leng B; Conri C
Presse Med; 1992 Jan 4-11; 21(1):27-30. PubMed ID: 1531260
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
17. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
J Infect Dis; 1992 Dec; 166(6):1223-7. PubMed ID: 1358986
[TBL] [Abstract][Full Text] [Related]
18. Rapid change in the use of antiretroviral agents and improvement in a population of HIV-infected patients: France, 1995-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
Spira R; Marimoutou C; Binquet C; Lacoste D; Dabis F
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):358-64. PubMed ID: 9704941
[TBL] [Abstract][Full Text] [Related]
19. Impact of opportunistic disease on survival in patients with HIV infection.
Chaisson RE; Gallant JE; Keruly JC; Moore RD
AIDS; 1998 Jan; 12(1):29-33. PubMed ID: 9456252
[TBL] [Abstract][Full Text] [Related]
20. Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. The Groupe d'Epidémiologie Clinique Du SIDA en Aquitaine.
Hocke C; Morlat P; Chene G; Dequae L; Dabis F
Obstet Gynecol; 1995 Dec; 86(6):886-91. PubMed ID: 7501333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
